Literature DB >> 15061432

Outpatient medication assistance program in a rural setting.

Gary N Harmon1, John Lefante, Wendy Roy, Keith H Ashby, Danny Jackson, David Barnard, Allen Smart, Larry Webber.   

Abstract

PURPOSE: Efforts to provide medication assistance to the rural poor in central Louisiana are described.
SUMMARY: The Central Louisiana Medication Access Program (CMAP) began functioning in 2001 with the objective of providing medication assistance and medication education to the rural poor in the community. The program serves individuals who use the outpatient clinic at the state-run public hospital in central Louisiana. Patients receive prescription drugs for a variety of chronic conditions, paying only a processing fee of dollar 3 per prescription, with a maximum outlay of dollar 15 per visit. A pharmacist counsels the patients about their medications. The medications are funded both through the program and through assistance programs run by pharmaceutical companies. A total of 5307 patients were enrolled in the CMAP between May 2001 and March 2003, and they received over 140,000 prescriptions at a cost saving to them in excess of dollar 2.5 million.
CONCLUSION: The CMAP has been able to provide prescription medications and medication counseling to needy patients in a rural environment at little cost to them.

Entities:  

Mesh:

Year:  2004        PMID: 15061432     DOI: 10.1093/ajhp/61.6.603

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  4 in total

1.  Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP).

Authors:  John J Lefante; Gary N Harmon; Keith M Ashby; David Barnard; Larry S Webber
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

2.  Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?

Authors:  Maria Pisu; Joshua Richman; Jeroan J Allison; O Dale Williams; Catarina I Kiefe
Journal:  South Med J       Date:  2009-02       Impact factor: 0.954

3.  Drug company-sponsored patient assistance programs: a viable safety net?

Authors:  Niteesh K Choudhry; Joy L Lee; Jessica Agnew-Blais; Colleen Corcoran; William H Shrank
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

4.  Serving underserved transplant recipients: experience of the Medication Access Program.

Authors:  Christina A Spivey; Marie A Chisholm-Burns; Charlene Garrett; Kenneth M Duke
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.